Skip to main content
Publications
Morris MJ, de Bono J, Nagarajah J, Sartor O, Wei XX, Nordquist LT, Koshkin VS, Chi KN, Krause BJ, Herrmann K, Rahbar K, Vickers A , Mirante O, Ghouse R, Fizazi K, Tagawa ST. Correlation analyses of radiographic progression-free survival with clinical and health-related quality of life outcomes in metastatic castration-resistant prostate cancer: analysis of the phase 3 VISION trial . Cancer. 2024 Oct 15;130(20):3426-35. doi: 10.1002/cncr.35438
Goldberg X, Castano-Vinyals G, Espinosa A, Carreras A, Liutsko L, Sicuri E, Foraster M , O'Callaghan-Gordo C, Dadvand P, Moncunill G, Dobano C, Cortes B, Pleguezuelos V, Straif K, Garcia-Aymerich J, de Cid R, Cardis E, Kogevinas M. Mental health and COVID-19 in a general population cohort in Spain (COVIVAT Study) . Soc Psychiatry Psychiatr Epidemiol. 2022 Dec;57(12):2457-68. doi: 10.1007/s00127-022-02303-0
Yland JJ, Eisenberg ML, Hatch EE, Rothman KJ , McKinnon CJ, Nillni YI, Sommer GJ, Wang TR, Wise LA. A North American prospective study of depression, psychotropic medication use, and semen quality . Fertil Steril. 2021 Sep;116(3):833-42. doi: 10.1016/j.fertnstert.2021.03.052
Reed SD, Saltus CW , Getahun D, Schoendorf J, Armstrong MA, Peipert JF, Raine-Bennett TR, Ritchey ME, Ichikawa LE, Zhou X , Fassett MJ, Alabaster A, Xie F, Merchant M, Chiu VY, Shi JM, Frenz A-K, Im TM, Takhar HS, Lynen R, Asiimwe A, Anthony MS . Menorrhagia and risk of intrauterine device (IUD) expulsion and uterine perforation: results from the APEX IUD study . Presented at the Virtual 76th Scientific Congress of the American Society for Reproductive Medicine (ASRM); October 17, 2020. [abstract] Fertil Steril. 2020 Sep 1; 114(3 Suppl):e12. doi: 10.1016/j.fertnstert.2020.08.059
Hunter JE, Zepp JM, Gilmore MJ, Davis JV, Esterberg EJ , Muessig KR, Peterson SK, Syngal S, Acheson LS, Wiesner GL, Reiss JA, Goddard KA. Universal tumor screening for Lynch syndrome: assessment of the perspectives of patients with colorectal cancer regarding benefits and barriers . Cancer. 2015 Sep 15;121(18):3281-9. doi: 10.1002/cncr.29470
Burris HA, Lebrun F, Rugo HS, Beck T, Piccart M, Neven P, Baselga J, Petrakova K, Hortobagyi GN, Komorowski A, Chouinard E, Young R, Gnant M, Pritchard KI, Bennett L , Ricci J-F, Bauly H, Taran T, Sahmoud T, Noguchi S. Health-related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO-2 trial . Cancer. 2013 Mar 15;119(10):1908-15.
Maurel J, Martins AS, Poveda A, Lopez-Guerrero JA, Cubedo R, Casado A, Martinez-Trufero J, Ramon Ayuso J, Lopez-Pousa A, Garcia-Albeniz X , Garcia del Muro X, de Alava E. Imatinib plus low-dose doxorubicin in patients with advanced gastrointestinal stromal tumors refractory to high-dose imatinib: a phase I-II study by the Spanish Group for Research on Sarcomas . Cancer. 2010 Aug 1;116(15):3692-701. doi: 10.1002/cncr.25111